Bain Capital Life Sciences Investors, LLC: ADCT position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Bain Capital Life Sciences Investors, LLC on ADCT, newest first. How the timeline and the estimate are built.
Bain Capital Life Sciences Investors, LLC reported 14,825,625 ADCT shares, 9.99%, in a 13G filed 2026-10-29.
Estimated current stake: 14,825,625 shares, 9.99% of the class
Estimated from 13G of 2026-10-29. As of 2026-10-22, 13G 0001193125-26-438199.
Shares are the reporting group's aggregate and may include entities that do not file a 13F.
- event date2026-10-2213G 14,825,625 sharesChange vs previous stake not available
9.99% of the class.
13G 0001193125-26-438199 filed by Bain Capital Life Sciences Opportunities IV, L.P.
Accepted , ingestedA 13D/G states the aggregate of its reporting persons, which may include entities that do not file a 13F.